Volume 112, Issue 4 pp. 435-441
Full Access

Neurofibromatous dermal hypoplasia: a clinical, pharmacological and ultrastructural study

J.F.B. NORRIS

J.F.B. NORRIS

Department of Dermatology and Central Pathology Laboratory, North Staffordshire Hospital Centre, Stoke-on-Trent, U.K.

Search for more papers by this author
A.G. SMITH

Corresponding Author

A.G. SMITH

Department of Dermatology and Central Pathology Laboratory, North Staffordshire Hospital Centre, Stoke-on-Trent, U.K.

Dr A.G. Smith, Consultant Dermatologist, Department of Dermatology, Central Out-Patients Department, Hartshill Road, Stoke-on-Trent ST4 7PA, U.K.Search for more papers by this author
P.J.H. FLETCHER

P.J.H. FLETCHER

Department of Dermatology and Central Pathology Laboratory, North Staffordshire Hospital Centre, Stoke-on-Trent, U.K.

Search for more papers by this author
T.L. MARSHALL

T.L. MARSHALL

Department of Dermatology and Central Pathology Laboratory, North Staffordshire Hospital Centre, Stoke-on-Trent, U.K.

Search for more papers by this author
M.J. HAND

M.J. HAND

Department of Dermatology and Central Pathology Laboratory, North Staffordshire Hospital Centre, Stoke-on-Trent, U.K.

Search for more papers by this author
First published: April 1985
Citations: 7

SUMMARY

Dermal hypoplasia is reported in three patients with neurofibromatosis. The areas of dermal hypoplasia failed to react to vasodilator stimuli and responded poorly to a vasoconstrictor stimulus. Histology of these lesions showed neurofibromatous tissue and at an ultrastructural level cells resembling perineurial cells were wrapped around dermal vessels. The poor vascular responses seen in these areas of neurofibromatous dermal hypoplasia might be due to the perineurial cells acting as a barrier to diffusion of the pharmacological agents and as a physical perivascular splint

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.